Duarri Anna, Nibbeling Esther A R, Fokkens Michiel R, Meijer Michel, Boerrigter Melissa, Verschuuren-Bemelmans Corien C, Kremer Berry P H, van de Warrenburg Bart P, Dooijes Dennis, Boddeke Erik, Sinke Richard J, Verbeek Dineke S
Department of Genetics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Department of Medical Physiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
PLoS One. 2015 Mar 10;10(3):e0116599. doi: 10.1371/journal.pone.0116599. eCollection 2015.
Spinocerebellar ataxia type 13 (SCA13) is an autosomal dominantly inherited neurodegenerative disorder of the cerebellum caused by mutations in the voltage gated potassium channel KCNC3. To identify novel pathogenic SCA13 mutations in KCNC3 and to gain insights into the disease prevalence in the Netherlands, we sequenced the entire coding region of KCNC3 in 848 Dutch cerebellar ataxia patients with familial or sporadic origin. We evaluated the pathogenicity of the identified variants by co-segregation analysis and in silico prediction followed by biochemical and electrophysiological studies. We identified 19 variants in KCNC3 including 2 non-coding, 11 missense and 6 synonymous variants. Two missense variants did not co-segregate with the disease and were excluded as potentially disease-causing mutations. We also identified the previously reported p.R420H and p.R423H mutations in our cohort. Of the remaining 7 missense variants, functional analysis revealed that 2 missense variants shifted Kv3.3 channel activation to more negative voltages. These variations were associated with early disease onset and mild intellectual disability. Additionally, one other missense variant shifted channel activation to more positive voltages and was associated with spastic ataxic gait. Whereas, the remaining missense variants did not change any of the channel characteristics. Of these three functional variants, only one variant was in silico predicted to be damaging and segregated with disease. The other two variants were in silico predicted to be benign and co-segregation analysis was not optimal or could only be partially confirmed. Therefore, we conclude that we have identified at least one novel pathogenic mutation in KCNC3 that cause SCA13 and two additionally potential SCA13 mutations. This leads to an estimate of SCA13 prevalence in the Netherlands to be between 0.6% and 1.3%.
13型脊髓小脑共济失调(SCA13)是一种常染色体显性遗传的小脑神经退行性疾病,由电压门控钾通道KCNC3的突变引起。为了鉴定KCNC3中新型致病的SCA13突变,并深入了解荷兰该疾病的患病率,我们对848名具有家族性或散发性起源的荷兰小脑共济失调患者的KCNC3整个编码区进行了测序。我们通过共分离分析和计算机预测评估已鉴定变异的致病性,随后进行生化和电生理研究。我们在KCNC3中鉴定出19个变异,包括2个非编码变异、11个错义变异和6个同义变异。两个错义变异与疾病不共分离,被排除为潜在致病突变。我们还在我们的队列中鉴定出先前报道的p.R420H和p.R423H突变。在其余7个错义变异中,功能分析显示,2个错义变异将Kv3.3通道激活转移到更负的电压。这些变异与疾病早发和轻度智力残疾相关。此外,另一个错义变异将通道激活转移到更正的电压,并与痉挛性共济失调步态相关。而其余错义变异未改变任何通道特征。在这三个功能性变异中,只有一个变异在计算机预测中被认为具有损害性且与疾病共分离。另外两个变异在计算机预测中被认为是良性的,共分离分析不理想或只能部分得到证实。因此,我们得出结论,我们在KCNC3中鉴定出至少一个导致SCA13的新型致病突变和另外两个潜在的SCA13突变。这使得荷兰SCA13患病率的估计值在0.6%至1.3%之间。